Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Medtronic
Queensland Health
Merck
Julphar
Chubb
Express Scripts
US Department of Justice

Generated: April 25, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,870,105

« Back to Dashboard

Summary for Patent: 4,870,105
Title: Phosphorus binder
Abstract:A composition for oral administration to an individual for the purpose of inhibiting gastrointestinal absorption of phosphorous, which includes calcium acetate. A method of inhibiting gastrointestinal absorption of phosphorous, comprising administering orally the composition, preferably close in time to food and beverage consumption.
Inventor(s): Fordtran; John S. (Dallas, TX)
Assignee: Braintree Laboratories, Inc. (Braintree, MA)
Application Number:07/035,341
Patent Claims: 1. A method for inhibiting gastrointestinal absorption of phosphorous in an individual, comprising:

orally ingesting a quantity of calcium acetate sufficient to bind with phosphorous in the gastrointestinal tract.

2. The method according to claim 1 wherein the calcium acetate is present in an amount sufficient to provide between 10 to 200 milliequivalents of calcium.

3. The method according to claim 1 wherein the calcium acetate is in tablet form.

4. The method according to claim 1 wherein the calcium acetate is in gelatin capsule form.

5. A method for inhibiting gastrointestinal absorption of phosphorous in an individual, comprising:

orally ingesting a quantity of calcium acetate at mealtimes.

6. The method according to claim 5 wherein the quantity of calcium acetate is present in an amount sufficient to produce between 10-200 milliequivalents of calcium.

7. The method according to claim 5 wherein the quantity of calcium acetate is in tablet form.

8. The method according to claim 5 wherein the quantity of calcium acetate is in gelatin capsule form.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Express Scripts
Johnson and Johnson
Dow
Boehringer Ingelheim
Chubb
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.